Diabetic retinopathy (DR)/diabetic macular edema (DME) affect a majority of patients with diabetes, but appropriate management of diabetes, vision screening, and timely referral to specialty eye care can help halt progression of the disease. This collection of activities offers practical strategies clinicians can use to empower patients to engage in recommended diabetic eye care (eg, screening, risk factor ), a look at the progressive nature of DR to underscore the importance of early intervention, and an overview of novel screening and diagnostic tools that can be used to expedite care.Accredited Activities
Found 8 Results
Guideline Directed Care for Screening All Patients With Newly Diagnosed Type 2 Diabetes
Patient Simulation
Credit Hours:
0.25 (15 min)
Missed Opportunity to Screen and Refer Early in Disease Management by Creating Guideline-Directed Care Plans
Patient Simulation
Credit Hours:
0.25 (15 min)
Diabetic Eye Care Prime Time™ Enduring: Meeting the Guidelines Around Screening and Treatment
News Broadcast
Credit Hours:
0.50 (30 min)
Best Practices in Referral to Retinal Specialists: Making Sense of the Guidelines
Patient Simulation
Credit Hours:
0.25 (15 min)
Making the Case for Early Recognition, Referral, and Treatment
Patient Simulation
Credit Hours:
0.25 (15 min)
Best Practices for Early Recognition and Referral to Treat Suspected Diabetic Macular Edema
Patient Simulation
Credit Hours:
0.25 (15 min)
Best Practices for Early Recognition and Referral to Evaluate Nonproliferative Diabetic Retinopathy
Patient Simulation
Credit Hours:
0.25 (15 min)
DR/DME Primer: Pathophysiology, Therapies, Standards of Care
Infographic
Credit Hours:
0.25 (15 min)
This initiative is provided by Paradigm Medical Communications, LLC.
In collaboration with the American Association of Nurse Practitioners, American Academy of Physician Associates, California Academy of Family Physicians, Center for Sustainable Health Care Quality and Equity, Endocrine Society, Global Education Group, National Minority Quality Forum, and Salus University Pennsylvania College of Optometry.
Supporter Acknowledgment
This initiative is supported by an independent medical educational grant from Regeneron Pharmaceuticals, Inc.
Paradigm Medical Communications, LLC presents this resource for educational purposes only. Healthcare professionals are expected to employ their own knowledge and judgement during any discussion with, or treatment of, their patients.
For questions, technical support, or playback issues, please email us at contactus@paradigmmc.com.
Sign up to receive notifications when new activities become available.